Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans

Proceedings of the National Academy of Sciences of the United States of America
Ian D DavisJonathan Cebon

Abstract

NY-ESO-1 is a "cancer-testis" antigen expressed in many cancers. ISCOMATRIX is a saponin-based adjuvant that induces antibody and T cell responses. We performed a placebo-controlled clinical trial evaluating the safety and immunogenicity of recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant. Forty-six evaluable patients with resected NY-ESO-1-positive tumors received three doses of vaccine intramuscularly at monthly intervals. The vaccine was well tolerated. We observed high-titer antibody responses, strong delayed-type hypersensitivity reactions, and circulating CD8(+) and CD4(+) T cells specific for a broad range of NY-ESO-1 epitopes, including known and previously unknown epitopes. In an unplanned analysis, vaccinated patients appeared to have superior clinical outcomes to those treated with placebo or protein alone. The vaccine is safe and highly potent immunologically.

References

Feb 26, 1993·Journal of Immunological Methods·T JungC Rieger
Feb 1, 1996·Immunology and Cell Biology·I G Barr, G F Mitchell
Feb 12, 1998·The Journal of Clinical Investigation·V KaranikasI F McKenzie
May 23, 1998·The Journal of Experimental Medicine·E StockertL J Old
Jun 17, 1998·International Journal of Cancer. Journal International Du Cancer·B LethéT Boon
Jun 24, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G GonzálezA Lage
Apr 26, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·J M Timmerman, R Levy
Apr 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·E JägerA Knuth
Jul 6, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·G ZengR F Wang
Sep 27, 2000·Proceedings of the National Academy of Sciences of the United States of America·S GnjaticL J Old
Oct 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·E JägerA Knuth
Dec 20, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·D RimoldiD Valmori
Mar 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·G ZengR F Wang
Apr 6, 2001·International Journal of Cancer. Journal International Du Cancer·L StaibD Herlyn
Dec 12, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·L FongE G Engleman
Dec 31, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M MarchandG Stoter
Jun 21, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yi ZhangPierre Van Der Bruggen
Jul 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·Sacha GnjaticLloyd J Old
Feb 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Djordje AtanackovicSacha Gnjatic

❮ Previous
Next ❯

Citations

Oct 15, 2009·Applied Microbiology and Biotechnology·Chung-Jr HuangCarl A Batt
Apr 28, 2010·Applied Microbiology and Biotechnology·Chung-Jr HuangCarl A Batt
Sep 28, 2005·Cancer Immunology, Immunotherapy : CII·Zhaojun SunPierre van der Bruggen
Mar 1, 2006·Cancer Immunology, Immunotherapy : CII·A G Dalgleish, M A Whelan
Dec 21, 2006·Cancer Immunology, Immunotherapy : CII·Barbara-Ann GuinnKen I Mills
Mar 4, 2008·Cancer Immunology, Immunotherapy : CII·Kazuhide TsujiKeiji Iwatsuki
Feb 18, 2009·Cancer Immunology, Immunotherapy : CII·Craig GedyeIan D Davis
Apr 27, 2013·Cancer Immunology, Immunotherapy : CII·Frank NeumannBoris Kubuschok
Sep 28, 2007·Journal of Cancer Research and Clinical Oncology·Yi ShaoHai-Tao Zhao
Nov 26, 2011·Medical Oncology·Tanja Badovinac ČrnjevićNera Šarić
Aug 9, 2005·Journal of Proteome Research·Karen S Anderson, Joshua LaBaer
Jul 22, 2005·Nature Reviews. Cancer·Andrew J G SimpsonLloyd J Old
Mar 22, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Barbara-ann GuinnAlbert B Deisseroth
Jun 16, 2004·Proceedings of the National Academy of Sciences of the United States of America·Qiyuan ChenWeisan Chen
Jan 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Djordje AtanackovicSacha Gnjatic
Dec 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jianda YuanJedd D Wolchok
Dec 18, 2008·Proceedings of the National Academy of Sciences of the United States of America·Oliver HofmannWinston Hide
Aug 5, 2009·Proceedings of the National Academy of Sciences of the United States of America·Anita GrigoriadisA Munro Neville
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Yao-Tseng ChenLloyd J Old
Nov 25, 2011·Proceedings of the National Academy of Sciences of the United States of America·Caroline JunqueiraRicardo T Gazzinelli
Sep 22, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jianda YuanSacha Gnjatic
Jul 9, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G CuriglianoA Goldhirsch
Oct 8, 2008·Nucleic Acids Research·Luiz Gonzaga AlmeidaAna Tereza R Vasconcelos
Jun 1, 2007·Applied Immunohistochemistry & Molecular Morphology : AIMM·Dirk JägerAchim A Jungbluth
Apr 27, 2010·Melanoma Research·Carolina SchinkeAmit Verma
Sep 29, 2011·The Cancer Journal·Teofila SeremetPierre G Coulie
Sep 9, 2009·Pigment Cell & Melanoma Research·Camilla JandusPedro Romero
Jul 9, 2008·Biochemistry. Biokhimii︠a︡·P V BelousovS A Nedospasov
Mar 23, 2006·Annual Review of Immunology·Thierry BoonPierre van der Bruggen
Jul 21, 2011·Journal of Drug Delivery·Aiala SalvadorJosé Luis Pedraz
Jun 14, 2013·Cell Communication and Signaling : CCS·Anja KoopHans-Jürgen Heidebrecht
Aug 24, 2010·Journal of Translational Medicine·Jochen T SchaeferCraig L Slingluff
Jun 17, 2006·Breast Cancer Research : BCR·Vasso ApostolopoulosStamatis Vassilaros
Nov 5, 2008·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Shinsaku Nakagawa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Qiyuan ChenWeisan Chen
Nature Reviews. Cancer
Andrew J G SimpsonL J Old
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Theo NicholaouJonathan Cebon
© 2022 Meta ULC. All rights reserved